Background: An excess storage of body fat causes obesity. Since obesity increases risk of chronic diseases, it is important to inhibit excessive storage of fat. Zaluzanin C is a sesquiterpene lactone isolated from Ainsliaea acerifolia. The aim of this study was to demonstrate the effect of zaluzanin C on differentiation of 3T3-L1 preadipocytes into mature adipocytes. Methods: The cytotoxicity of zaluzanin C and its effect on cell proliferation was determined. For the induction of adipocyte differentiation, 3T3-L1 preadipocytes were treated with differentiating medium containing 10 μg/mL insulin, 115 μg/mL methylisobutylxanthine, and 1 μM dexamethasone. Differentiated 3T3-L1 cells were subjected to Oil red O solution or used for Western blot analysis. Zaluzanin C was added to the cell culture medium at concentrations of 0, 1, 2.5, 5, and 10 μM. Results: Zaluzanin C did not inhibit cell proliferation and showed no cytotoxicity at 10 μM concentration in 3T3-L1 cells. Therefore, concentration range of 0-10 μM zaluzanin C was used for subsequent experiments. Zaluzanin C inhibited accumulation of lipid droplets in 3T3-L1 adipocytes. To understand the underlying mechanism of zaluzanin C, expression of adipogenesis regulators was determined by Western blot analysis. Zaluzanin C suppressed peroxisome proliferator-activated receptor gamma (PPARγ) expression, an adipogenesis related transcription factor, and inhibited aP2/fatty acid-binding protein-4 expression, a target gene of PPARγ. However, it did not affect expression of CCAAT/enhancer-binding protein alpha related with acquisition of insulin sensitivity. Conclusion: These data suggest that inhibitory effect of zaluzanin C on adipogenesis of 3T3-L1 adipocytes could be partially caused by suppressing PPARγ.
INTRODUCTION
Prevalence rate of obesity has increased since 1988. Particularly, it was 42.3% among males in South Korea in 2016. 1 Obesity is a significant risk factor for many serious illnesses such as gastrointestinal cancer, heart disease, stroke and diabetes. [2] [3] [4] [5] Increased physical activity, diet modification, drugs, and surgery are common strategies to treat obesity. 6 Currently available anti-obesity drugs are associated with several adverse effects such as hyperthyroidism, palpitations, anxiety, insomnia, and diarrhea. 7 Therefore, there is a growing demand for the development of new and safe anti-obesity agents.
Imbalance between energy intake and its consumption can lead
to an excessive accumulation of lipids in the adipose tissue. Adipose tissue is a key regulator of energy balance, playing an active role in lipid storage and buffering, synthesizing, and secreting a wide range of endocrine products into blood circulation that influence systemic metabolism. 8 Therefore, inhibition of adipogenesis in adipocytes could be a good strategy to prevent and treat obesity.
that zaluzanin C, a sesquiterpene lactone mainly isolated from family Compositae, exhibits anti-fungal, anti-inflammatory and anticancer activities, and osteoblastic differentiation potential. [10] [11] [12] [13] [14] [15] [16] [17] However, its effect on differentiation of 3T3-L1 preadipocytes remains uncertain. Therefore, this study aimed to investigate whether zaluzanin C affects the differentiation of 3T3-L1 preadipocytes into mature adipocytes.
METHODS

Reagents
For cell culture, bovine calf serum (BCS), fetal bovine serum BCS, 100 U/mL penicillin and 100 μg/mL streptomycin. Cells were maintained at 37°C in a humidified incubator with 5% CO2.
Cell differentiation
For the induction of adipocyte differentiation, 3T3-L1 preadipocytes were seeded at a density of 5 × 10 4 cells/mL/well in a 24-well plate. As shown in Fig. 1 , at confluence (day 0), the cultured preadipocytes were induced to differentiate by the addition of differentiating medium (DMEM containing 115 μg/mL IBMX, 10 μg/mL insulin, and 1 μM dexamethasone) from day 0 to day 6. At day 6, medium was changed with medium containing 10 μg/mL insulin for an additional 6 days from day 6 to day 12. The medium was refreshed every 3 days. At day 12, differentiated 3T3-L1 cells were subjected to Oil red O solution or used for Western blot analysis.
Zaluzanin C was dissolved in dimethyl sulfoxide (DMSO) and was added to the cell culture medium at concentrations of 0, 1, 2.5, 5, and 10 μM from day 0 to day 12 ( Fig. 1 ). Light microscopy and
Oil red O staining were used to monitor the characteristic cell rounding and lipid accumulation during the cell differentiation, respectively.
Oil red O staining
After cell differentiation, cells were fixed with 1 mL of 10% form- 
Cell proliferation and cytotoxicity assay
The cytotoxicity of zaluzanin C and its effect on cell proliferation was determined using CytoTox96 Non-Radioactive Cytotoxicity 
Preparation of whole cell lysates
To prepare whole cell lysate, cells were lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 50 mM sodium fluoride (NaF), 30 mM sodium pyrophosphate (Na4P2O7), 1 mM phenylmethanesulfonyl fluoride, 2 mg/mL aprotinin, and 1 mM pervanadate. The lysates were clarified by centrifugation at 12,000 × g for 15 minutes at 4°C.
The lysates were stored at -80°C until needed.
Western blotting analysis
Proteins in whole cell lysates were separated by 10% sodium do- 
Statistical analysis
GraphPad Prism version 5.0 software (GraphPad, San Diego, CA, USA) was used for statistical analysis. The data were expressed Figure 1 . Experimental scheme. For the induction of adipocyte differentiation, 3T3-L1 preadipocytes were seeded. At confluence (day 0), the cultured preadipocytes were induced to differentiate by the addition of differentiating medium containing 115 μg/mL methylisobutylxanthine (IBMX), 10 μg/mL insulin, and 1 μM dexamethasone (Dex) from day 0 to day 6. At day 6, medium was changed with medium containing 10 μg/mL insulin for an additional 6 days from day 6 to day 12. The medium was refreshed every 3 days. At day 12, differentiated 3T3-L1 cells were subjected to Oil red O solution or used for Western blot analysis. Zaluzanin C was added to the cell culture medium at concentrations of 0, 1, 2.5, 5, and 10 μM from day 0 to day 12. DMEM, Dulbecco's modified Eagle's medium. 
as the mean ± standard error of the mean of three independent experiments. Differences between the mean values of multiple groups were analyzed using one-way analysis of variance with Dunnett test or Tukey's test. A P< 0.05 was considered as statistically significant.
RESULTS
As part of our ongoing screening program, antiadipogenic potentials of 11 types of bioactive compounds were evaluated. 20 According to Kwak's study 20 , 10 μM zaluzanin C inhibited lipid accumulation, a characteristic of differentiated adipocytes 21, 22 , in 3T3-L1 adipocytes. Based on this result, antiadipogenic potential of zaluzanin C and its underlying mechanism was evaluated in the subsequent experiments.
As 10 μM zaluzanin C was shown to inhibit lipid accumulation in 3T3-L1 adipocytes, its effect was examined on cell proliferation and cytotoxicity in 3T3-L1 preadipocytes. Since zaluzanin C did not inhibit cell proliferation and showed no cytotoxicity up to 10 μM concentration (Fig. 2) , it was indicated that its inhibitory effect against lipid accumulation was not related to its cytotoxicity or antiproliferative effect. Therefore, zaluzanin C was used at a concentration range of 0-10 μM for the subsequent experiments.
To evaluate the effect of zaluzanin C on lipid accumulation during adipogenesis of 3T3-L1 preadipocytes, intracellular lipid content was measured at day 12 using Oil red O staining. The absorbance value of the negative control was 0.04 and that of 0 μM zaluzanin C was 0.14 ( Fig. 3) . Differentiation medium induced an increase in absorbance up to 350% in cells treated with 0 μM zaluzanin C compared to the negative control group (Fig. 3 ).
An understanding of the process of adipose formation and the mechanisms that govern adipogenesis is vital in the fight against the growing incidence of obesity. 23 Therefore, attenuation of the expression of adipogenic related transcription factors, such as PPARγ and C/EBPα by zaluzanin C was evaluated using Western blot analysis. At day 12, PPARγ expression was significantly increased in 0 μM zaluzanin group compared to the negative control group (Fig. 4) . Zaluzanin C effectively inhibited the differentiation medium-induced increase of PPARγ expression in 3T3-L1 adipocytes at concentrations greater than 1 μM. Then, expression of , maintenance of C/EBPα by treatment of zaluzanin C has significant meaning in improving insulin resistance that occur by excess lipid accumulation. PPARγ is capable of promoting adipogenesis in C/EBPα-deficient cells, whereas C/EBPα is incapable of promoting adipogenesis in PPARγ-deficient cells.
These findings demonstrate that PPARγ is a more important master regulator of adipogenesis than C/EBPα. 30 This is the first study to demonstrate that zaluzanin C inhibits differentiation of preadipocytes to mature adipocytes. These data suggest that zaluzanin C particularly affects PPARγ, a key transcription factor for adipogenesis, and does not inhibit the process which acquires insulin sensitivity. Although this study does not reveal how zaluzanin C selectively regulate expression of PPARγ and C/EBPα, previous studies have demonstrated that zaluzanin C exhibited the most potent inhibitory effect in advanced glycation end products, which is valuable therapeutic targets for the regulation of diabetic complications. 33 Also, zaluzanin C inhibited α-glucosidase activity which is one of the targets for treatment of diabetes. 18 As C/EBPα is an essential factor in which adipocytes acquire insulin sensitivity, maintenance of C/EBPα by treatment of zaluzanin C could positively affect improvement of obesity related diabetes. However, further study is needed to evaluate molecular mechanisms on how zaluzanin C increase expression of C/EBPα. In conclusion, zaluzanin C may be a potential source for the treatment of obesity.
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